Health care companies by P/E ratio
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Charles River Laboratories International leads the 115 health care companies ranked by P/E ratio, at 356, ahead of Takeda Pharmaceutical (306) and Waters (191). Figures as of 19 Nov 2026, 21:22 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 115
- First
- Charles River Laboratories International356
- Median
- 30.2
- Combined market value
- MX$170.29T
- Countries
- 14
- Not ranked
- 55no P/E ratio on file
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | P/E ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Charles River Laboratories InternationalCRL · Health Care | 356 | MX$299.9B | MX$6,259.43 | 1.60% down | 106% up | ||
| 2 | Takeda PharmaceuticalTAK · Health Care | 306 | MX$1.31T | MX$408.67 | 0.66% up | 51% up | ||
| 3 | WatersWAT · Health Care | 191 | MX$1.71T | MX$8,713.15 | 2.06% down | 23% up | ||
| 4 | Merck & CoMRK · Health Care | 134 | MX$6.25T | MX$2,535.04 | 3.61% down | 45% up | ||
| 5 | Ligand PharmaceuticalsLGND · Health Care | 115 | MX$109.6B | MX$5,477.02 | 3.94% down | 50% up | ||
| 6 | BiogenBIIB · Health Care | 107 | MX$697.3B | MX$4,717.14 | 1.70% down | 49% up | ||
| 7 | BillionToOneBLLN · Health Care | 98.0 | MX$82.3B | MX$1,721.71 | 1.46% down | 4% down | ||
| 8 | TG TherapeuticsTGTX · Health Care | 96.8 | MX$187.2B | MX$1,238.41 | 1.88% down | 117% up | ||
| 9 | SolventumSOLV · Health Care | 96.4 | MX$278.3B | MX$1,637.72 | 0.79% down | 9% up | ||
| 10 | Teva Pharmaceutical IndustriesTEVA · Health Care | 89.6 | MX$858.4B | MX$735.64 | 8.74% down | 74% up | ||
| 11 | MedlineMDLN · Health Care | 86.0 | MX$950.5B | MX$722.28 | 3.37% down | 4% down | ||
| 12 | PenumbraPEN · Health Care | 80.6 | MX$240.8B | MX$6,108.25 | 0.18% down | 15% up | ||
| 13 | TeleflexTFX · Health Care | 80.5 | MX$123.7B | MX$3,118.93 | 1.48% down | 58% up | ||
| 14 | ICONICLR · Health Care | 76.1 | MX$272.2B | MX$3,633.53 | 2.46% down | 23% up | ||
| 15 | LifeStance Health GroupLFST · Health Care | 74.1 | MX$96.8B | MX$254.63 | 3.12% down | 123% up | ||
| 16 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 70.9 | MX$140.3B | MX$1,785.37 | 1.59% down | 129% up | ||
| 17 | Jazz PharmaceuticalsJAZZ · Health Care | 70.0 | MX$289.7B | MX$4,513.29 | 4.57% down | 41% up | ||
| 18 | RevvityRVTY · Health Care | 67.4 | MX$323B | MX$2,893.50 | 0.55% down | 62% up | ||
| 19 | Bio-TechneTECH · Health Care | 66.7 | MX$218B | MX$1,387.68 | 0.07% down | 24% up | ||
| 20 | HeartflowHTFL · Health Care | 66.6 | MX$74.9B | MX$851.88 | 2.75% down | 66% up | ||
| 21 | Edwards LifesciencesEW · Health Care | 60.4 | MX$1.14T | MX$1,982.83 | 1.28% down | 25% up | ||
| 22 | IncyteINCY · Health Care | 59.1 | MX$450.8B | MX$2,211.69 | 1.64% down | 16% up | ||
| 23 | AlconALC · Health Care | 54.4 | MX$683.1B | MX$1,422.03 | 1.01% down | 0% up | ||
| 24 | Amneal PharmaceuticalsAMRX · Health Care | 53.5 | MX$142.3B | MX$408.29 | 2.24% down | 90% up | ||
| 25 | HaemoneticsHAE · Health Care | 53.3 | MX$104.6B | MX$2,297.59 | 2.03% down | 64% up | ||
| 26 | BeOne MedicinesONC · Health Care | 51.2 | MX$871.5B | MX$7,629.35 | 0.97% down | 16% up | ||
| 27 | Intuitive SurgicalISRG · Health Care | 49.2 | MX$2.69T | MX$7,773.27 | 3.26% down | 24% down | ||
| 28 | Corcept TherapeuticsCORT · Health Care | 48.9 | MX$135.7B | MX$1,240.32 | 4.15% down | 10% down | ||
| 29 | AbbVieABBV · Health Care | 48.7 | MX$9.57T | MX$5,412.13 | 0.86% down | 25% up | ||
| 30 | IDEXX LaboratoriesIDXX · Health Care | 46.5 | MX$1.04T | MX$13,163.83 | 1.26% down | 1% up | ||
| 31 | BrightSpring Health ServicesBTSG · Health Care | 45.4 | MX$243.2B | MX$1,221.99 | 6.32% down | 109% up | ||
| 32 | West Pharmaceutical ServicesWST · Health Care | 44.5 | MX$527.5B | MX$7,571.90 | 1.81% down | 57% up | ||
| 33 | Royalty PharmaRPRX · Health Care | 44.3 | MX$743.2B | MX$1,292.62 | 1.38% down | 79% up | ||
| 34 | GenmabGMAB · Health Care | 43.9 | MX$604.4B | MX$980.15 | 0.75% up | 70% up | ||
| 35 | Eli LillyLLY · Health Care | 43.9 | MX$22.97T | MX$25,789.77 | 2.29% down | 33% up | ||
| 36 | Krystal BiotechKRYS · Health Care | 42.9 | MX$178.6B | MX$6,028.28 | 0.15% up | 54% up | ||
| 37 | Becton, DickinsonBDX · Health Care | 42.0 | MX$1.11T | MX$4,059.57 | 1.57% down | 45% up | ||
| 38 | Dr. Reddy's LaboratoriesRDY · Health Care | 41.2 | MX$236B | MX$283.07 | 1.00% down | 8% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | 40.5 | MX$12.28T | MX$5,099.09 | 2.04% down | 34% up | ||
| 40 | PfizerPFE · Health Care | 39.3 | MX$3T | MX$525.68 | 1.85% down | 15% up | ||
| 41 | Abbott LaboratoriesABT · Health Care | 38.8 | MX$3.43T | MX$1,982.64 | 0.58% down | 16% down | ||
| 42 | DanaherDHR · Health Care | 37.7 | MX$3.06T | MX$4,343.60 | 0.45% down | 3% up | ||
| 43 | HumanaHUM · Health Care | 37.1 | MX$871.1B | MX$7,253.33 | 1.50% down | 73% up | ||
| 44 | Mettler-Toledo InternationalMTD · Health Care | 37.0 | MX$647.6B | MX$32,557.13 | 1.82% down | 24% up | ||
| 45 | Thermo Fisher ScientificTMO · Health Care | 36.3 | MX$4.87T | MX$13,146.65 | 0.58% down | 21% up | ||
| 46 | Cardinal HealthCAH · Health Care | 35.2 | MX$1.2T | MX$5,198.34 | 2.15% down | 34% up | ||
| 47 | Medpace HoldingsMEDP · Health Care | 35.2 | MX$338.5B | MX$12,101.22 | 1.99% down | 10% up | ||
| 48 | HealthEquityHQY · Health Care | 35.2 | MX$153.7B | MX$1,858.76 | 0.07% up | 3% down | ||
| 49 | Agilent TechnologiesA · Health Care | 34.6 | MX$943.7B | MX$3,346.84 | 1.12% down | 22% up | ||
| 50 | IlluminaILMN · Health Care | 34.5 | MX$579.1B | MX$3,830.04 | 4.45% down | 76% up | ||
| 51 | Vertex PharmaceuticalsVRTX · Health Care | 33.5 | MX$2.52T | MX$9,938.20 | 2.94% down | 27% up | ||
| 52 | StrykerSYK · Health Care | 33.3 | MX$2.28T | MX$5,975.98 | 1.59% down | 12% down | ||
| 53 | argenxARGX · Health Care | 32.6 | MX$1.13T | MX$17,981.38 | 0.08% up | 2% up | ||
| 54 | Merit Medical SystemsMMSI · Health Care | 31.6 | MX$96.5B | MX$1,611.19 | 1.77% down | 1% up | ||
| 55 | DexComDXCM · Health Care | 31.6 | MX$570.9B | MX$1,530.64 | 2.82% down | 41% up | ||
| 56 | IQVIA HoldingsIQV · Health Care | 30.5 | MX$788.1B | MX$4,782.42 | 2.83% down | 19% up | ||
| 57 | AvantorAVTR · Health Care | 30.2 | MX$195.6B | MX$288.61 | 1.63% down | 40% up | ||
| 58 | Labcorp HoldingsLH · Health Care | 30.2 | MX$571.7B | MX$7,041.07 | 0.51% down | 42% up | ||
| 59 | STERISSTE · Health Care | 30.2 | MX$472.2B | MX$4,862.78 | 1.85% down | 1% up | ||
| 60 | NovartisNVS · Health Care | 28.9 | MX$5.45T | MX$2,886.44 | 2.57% down | 25% up | ||
| 61 | McKessonMCK · Health Care | 27.4 | MX$2.34T | MX$20,274.19 | 2.05% down | 28% up | ||
| 62 | QiagenQGEN · Health Care | 26.8 | MX$195.6B | MX$947.32 | 0.14% up | 9% up | ||
| 63 | ChemedCHE · Health Care | 26.4 | MX$136.4B | MX$10,523.62 | 0.84% up | 27% up | ||
| 64 | LivaNovaLIVN · Health Care | 26.4 | MX$96.8B | MX$1,757.40 | 2.61% down | 77% up | ||
| 65 | Ensign GroupENSG · Health Care | 26.3 | MX$196.6B | MX$3,370.70 | 3.49% down | 2% up | ||
| 66 | Protagonist TherapeuticsPTGX · Health Care | 26.2 | MX$154.5B | MX$2,367.26 | 2.47% down | 51% up | ||
| 67 | Quest DiagnosticsDGX · Health Care | 25.8 | MX$544.1B | MX$4,945.43 | 0.23% down | 38% up | ||
| 68 | Zimmer Biomet HoldingsZBH · Health Care | 25.6 | MX$366.6B | MX$1,936.83 | 1.79% down | 16% up | ||
| 69 | AmgenAMGN · Health Care | 25.4 | MX$4.53T | MX$8,376.06 | 1.14% down | 32% up | ||
| 70 | Koninklijke PhilipsPHG · Health Care | 25.4 | MX$545.8B | MX$558.32 | 1.88% down | 12% up | ||
| 71 | Lantheus HoldingsLNTH · Health Care | 25.4 | MX$127.5B | MX$1,948.85 | 0.10% up | 90% up | ||
| 72 | AstraZenecaAZN · Health Care | 24.8 | MX$5.19T | MX$3,348.17 | 1.87% down | 1% up | ||
| 73 | MedtronicMDT · Health Care | 24.7 | MX$2.46T | MX$1,920.41 | 0.11% down | 1% up | ||
| 74 | Concentra Group Holdings ParentCON · Health Care | 24.5 | MX$99.5B | MX$791.19 | 1.12% down | 116% up | ||
| 75 | PACS GroupPACS · Health Care | 24.4 | MX$130.4B | MX$821.34 | 7.06% down | 77% up | ||
| 76 | Align TechnologyALGN · Health Care | 23.3 | MX$214.8B | MX$3,047.92 | 2.61% down | 23% up | ||
| 77 | Halozyme TherapeuticsHALO · Health Care | 23.3 | MX$202.5B | MX$1,775.92 | 2.88% down | 39% up | ||
| 78 | Neurocrine BiosciencesNBIX · Health Care | 23.2 | MX$302.5B | MX$2,988.94 | 3.85% down | 17% up | ||
| 79 | Henry ScheinHSIC · Health Care | 23.2 | MX$178.9B | MX$1,618.64 | 1.04% down | 20% up | ||
| 80 | SanofiSNY · Health Care | 22.9 | MX$2.11T | MX$879.18 | 2.25% down | 4% down | ||
| 81 | Option Care HealthOPCH · Health Care | 22.9 | MX$90.4B | MX$603.36 | 0.32% down | 12% up | ||
| 82 | MSA SafetyMSA · Health Care | 22.6 | MX$129.6B | MX$3,364.02 | 0.68% down | 16% up | ||
| 83 | CenteneCNC · Health Care | 22.5 | MX$619.7B | MX$1,251.77 | 2.77% down | 94% up | ||
| 84 | InsuletPODD · Health Care | 22.4 | MX$181.7B | MX$2,619.41 | 1.96% down | 55% down | ||
| 85 | ResMedRMD · Health Care | 21.6 | MX$636B | MX$4,521.49 | 2.36% down | 1% down | ||
| 86 | Encompass HealthEHC · Health Care | 21.2 | MX$247.8B | MX$2,524.92 | 1.96% down | 20% up | ||
| 87 | United TherapeuticsUTHR · Health Care | 21.1 | MX$454.5B | MX$10,671.93 | 3.16% down | 22% up | ||
| 88 | Cooper CompaniesCOO · Health Care | 20.7 | MX$219B | MX$1,151.56 | 0.69% down | 15% down | ||
| 89 | Regeneron PharmaceuticalsREGN · Health Care | 20.4 | MX$1.82T | MX$17,624.44 | 2.35% down | 28% up | ||
| 90 | Smith & NephewSNN · Health Care | 20.3 | MX$238.1B | MX$569.39 | 1.62% down | 5% down | ||
| 91 | ExelixisEXEL · Health Care | 19.7 | MX$306.6B | MX$1,256.54 | 3.60% down | 63% up | ||
| 92 | CencoraCOR · Health Care | 19.0 | MX$1.24T | MX$6,513.68 | 2.03% down | 4% down | ||
| 93 | UnitedHealth GroupUNH · Health Care | 18.9 | MX$5.65T | MX$6,308.10 | 5.55% down | 12% up | ||
| 94 | Boston ScientificBSX · Health Care | 18.1 | MX$1.19T | MX$820.58 | 1.49% down | 55% down | ||
| 95 | GE HealthCare TechnologiesGEHC · Health Care | 17.3 | MX$706.7B | MX$1,563.09 | 2.12% down | 12% up | ||
| 96 | Globus MedicalGMED · Health Care | 16.9 | MX$173.5B | MX$1,309.42 | 2.74% down | 14% down | ||
| 97 | Ascendis PharmaASND · Health Care | 16.8 | MX$320.5B | MX$4,885.69 | 5.32% down | 29% up | ||
| 98 | GSKGSK · Health Care | 16.7 | MX$1.83T | MX$912.77 | 1.56% down | 5% up | ||
| 99 | Elevance HealthELV · Health Care | 16.6 | MX$1.61T | MX$7,447.26 | 2.66% down | 28% up | ||
| 100 | HCA HealthcareHCA · Health Care | 15.3 | MX$1.84T | MX$8,786.64 | 3.36% down | 0% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 19.0877 MXN). 55 companies have no P/E ratio on file and are not ranked here.
Questions and answers
Which health care companies rank first by P/E ratio?
Charles River Laboratories International (356), Takeda Pharmaceutical (306) and Waters (191) are the top three of the 115 health care companies ranked by P/E ratio as of 19 Nov 2026, 21:22 UTC.
How many health care companies are in this ranking?
115 are ranked by P/E ratio. 55 more have no P/E ratio on file and are left out rather than ranked at zero.
What are these health care companies worth together?
The 115 health care companies ranked by P/E ratio have a combined market value of MX$170.29T as of 19 Nov 2026, 21:22 UTC.
What does ranking by P/E ratio measure?
Share price divided by the last twelve months' earnings per share: how many years of today's profit the price pays for. A company making a loss has none.
Learn how this ranking works
All markets guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies by P/E ratio”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=pe-ratio
Underlying data: Yahoo Finance; SEC EDGAR.